Rilapladib
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Rilapladib, covering 2015-04-15 to 2018-09-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease [Phase 2]